Font Size: a A A

Clinical Study On The Internal And External Treatment Of Profiting Spleen And Kidney To Copd Prognostic Indicators

Posted on:2013-03-14Degree:MasterType:Thesis
Country:ChinaCandidate:T TianFull Text:PDF
GTID:2234330371498037Subject:Chinese medical science
Abstract/Summary:PDF Full Text Request
Purpose:The topics is on the basis of traditional Chinese medicine dialectical theory, to observe the prognostic indicators of stable COPD, using the internal and external treatment of profiting spleen and Kidney.By studying the Lung function, The body—mass index, The BODE comprehensive evaluation, Recurrence rate. To investigate the efficacy of mechanism.Method:To Select72stable COPD patients, and Divide them into two groups with Simple digital random, Both groups used the conventional treatment of modern medicine and gu ben sheng jin Decoction, The treatment group choose the Catgut implantation at acupoint, Treatment for2months. Mainly observed in clinical efficacy and the change between before and after in Lung function The body—mass index The BODE comprehensive evaluation Recurrence rate.Result:1、94.4%the treatment group94.4%than the control group88.9%, efficacy differences (P<0.05).2、Improved in Cough, expectoration, weakness, abnormal stools and chest tighgteen. in the Wheezing shortness of breath, weakness, poor appetite and indigestion, and abnormal stools, the treatment group is better than the control group,(P<0.05).3、In lung function side FVC, FVC,%FEV1, FEV1%, FEV1/FVC ratio both improved, but the treatment group is not better than control group (P>0.05).4、In the Quality of life indicators index, The total accumulation (TMS), quality of life of everyday life the capacity factor (F1S), symptoms of depression and psychological factors (F3S), anxiety and psychological symptoms factor (F4S) aspects of group differences P<0.05; to improve the symptoms of depression and psychological factors (F3S), anxiety and psychological symptoms factor (F4S) between treatment and control group, group differences (P<0.05).5、In The BODE comprehensive evaluation, BMI, and the MRC observe the index group, there were no differences between groups (P>0.05), FEV1as above,6minutes walking distance, walking due to the treatment, no difference between groups after treatment (P>0.05).6、In the3months after the recurrence rate, treatment group is less than the control group(P>0.05).Conelusion:The Internal and External Treatment Of Profiting Spleen and Kidney, could improve the clinical symptoms of patients with COPD who are Lung, spleen and kidney qi deficiency.
Keywords/Search Tags:chronic obstructive pulmonary disease, profiting spleen and kidney, internal and external governance, catgut embedding, lung spleenand kidney qi deficiency type
PDF Full Text Request
Related items
Clinical Observation Of Qinglong Pingchuan Decoction On Lung-kidney Qi Deficiency And External Cold And Internal Drink Syndrome In Acute Exacerbation Of Senile Chronic Obstructive Pulmonary Disease
Clinical Research Based On Xin’an Medicine Compensating Qi Method Of Intervention In Chronic Obstructive Pulmonary Disease In Stabilization Period Of Lung And Kidney Deficiency Syndrome
Clinical Observation Bushenyifei Explore Rehabilitation Treatment Of Chronic Obstructive Pulmonary Disease Stabilization Period (Lung And Kidney Qi Deficiency Type)
Clinical Study Of A New Jiayu Screen Decoction In The Treatment Of Chronic Obstructive Pulmonary Disease Of Lung And Kidney Qi Deifciency And Phlegm And Blood Stasis Type
Clinical Research Of Fujian Decoction On The Stable Chronic Obstructive Pulmonary Diseases In Patients Of Lung Spleen And Kidney Deficiency
Clinical Curative Effect Observation Of Lung And Kidney Deficiency Syndrome Of Chronic Obstructive Pulmonary Disease Stable Phase By Invigorating Lung And Kidney Decoction
A Randomized Controlled Study On The Treatment Of Chronic Obstructive Pulmonary Disease With Pulmonary Fibrosis(COPD-PF) At Stable Period By Peibenning Lung And Yishen Tongluo Therapy
Tune Up The Treatment Of Chronic Obstructive Pulmonary Disease With Stable Clinical Efficacy Evaluation Index System Of The Lung And Kidney France
Clinical Observation On The Treatment Of Spleen And Kidney Deficiency Syndrome In Stable Stage Of Chronic Obstructive Pulmonary Disease With Self-prescribed Guben Decoctio
10 Professor Songkang:Evaluation Of The Therapeutic Effect Of Nourishing Lung,Spleen And Kidney On Chronic Obstructive Pulmonary Disease